Decorin-mediated Transforming Growth Factor-β Inhibition Ameliorates Adverse Cardiac Remodeling

Journal of Heart and Lung Transplantation

Volumn 26, Issue 1, 2007, Pages 34-40

  Jahanyar, Jama ^a   Joyce, David L ^a   Southard, Robert E ^a   Loebe, Matthias ^a,b   Noon, George P ^a,b   Koerner, Michael M ^a,b   Torre Amione, Guillermo ^b   Youker, Keith A ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; DECORIN; MESSENGER RNA; MOLECULAR MARKER; PROTEOGLYCAN; SCLEROPROTEIN; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; COLLAGEN SYNTHESIS; CONGESTIVE HEART FAILURE; FEMALE; FIBROBLAST; GENE EXPRESSION; HEART ASSIST DEVICE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REMISSION; RNA TRANSCRIPTION; UPREGULATION;

ADOLESCENT; ADULT; AGED; CELLS, CULTURED; COLLAGEN; ENDOMYOCARDIAL FIBROSIS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEOGLYCANS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 33846233906     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.10.005     Document Type: Article

References (38)

1. Bruckner B.A., Stetson S.J., Farmer J.A., et al. The implications for cardiac recovery of left ventricular assist device support on myocardial collagen content. Am J Surg 180 (2000) 498-501
2. Bruckner B.A., Razeghi P., Stetson S., et al. Degree of cardiac fibrosis and hypertrophy at time of implantation predicts myocardial improvement during left ventricular assist device support. J Heart Lung Transplant 23 (2004) 36-42
3. Scheinin S.A., Capek P., Radovancevic B., Duncan J.M., McAllister Jr. H.A., and Frazier O.H. The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy. ASAIO J 38 (1992) M271-M274
4. Barton P.J., Birks E.J., Felkin L.E., Cullen M.E., Koban M.U., and Yacoub M.H. Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure. J Heart Lung Transplant 22 (2003) 738-744
5. Bruckner B.A., Stetson S.J., Perez-Verdia A., et al. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant 20 (2001) 457-464
6. Li Y.Y., Feng Y., McTiernan C.F., et al. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation 104 (2001) 1147-1152
7. Janicki J.S., Brower G.L., Gardner J.D., Chancey A.L., and Stewart Jr. J.A. The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling. Heart Fail Rev 9 (2004) 33-42
8. Vogel K.G., and Trotter J.A. The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. Coll Relat Res 7 (1987) 105-114
9. Brown D.C., and Vogel K.G. Characteristics of the in vitro interaction of a small proteoglycan (PG II) of bovine tendon with type I collagen. Matrix 9 (1989) 468-478
10. Thieszen S.L., and Rosenquist T.H. Expression of collagens and decorin during aortic arch artery development: implications for matrix pattern formation. Matrix Biol 14 (1995) 573-582
11. Vogel K.G., Paulsson M., and Heinegard D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 223 (1984) 587-597
12. Hao J., Ju H., Zhao S., Junaid A., Scammell-La F.T., and Dixon I.M. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol 31 (1999) 667-678
13. Hildebrand A., Romaris M., Rasmussen L.M., et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 302 (1994) 527-534
14. Costacurta A., Priante G., D'Angelo A., Chieco-Bianchi L., and Cantaro S. Decorin transfection in human mesangial cells downregulates genes playing a role in the progression of fibrosis. J Clin Lab Anal 16 (2002) 178-186
15. Skrabal C.A., Thompson L.O., Southard R.E., et al. Interaction between isolated human myocardial mast cells and cultured fibroblasts. J Surg Res 118 (2004) 66-70
16. Pauschinger M., Chandrasekharan K., Li J., Schwimmbeck P.L., Noutsias M., and Schultheiss H.P. Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy. [in German]. Herz 27 (2002) 677-682
17. Mujumdar V.S., and Tyagi S.C. Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure. J Hypertens 17 (1999) 261-270
18. Weber K.T., Brilla C.G., Campbell S.E., Zhou G., Matsubara L., and Guarda E. Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure. Blood Press 1 (1992) 75-85
19. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200 (2003) 448-464
20. Li J., Zhang Y.P., and Kirsner R.S. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc Res Techn 60 (2003) 107-114
21. Schonherr E., and Hausser H.J. Extracellular matrix and cytokines: a functional unit. Dev Immunol 7 (2000) 89-101
22. Stupack D.G., and Cheresh D.A. Apoptotic cues from the extracellular matrix: regulators of angiogenesis. Oncogene 22 (2003) 9022-9029
23. Petrov V.V., Fagard R.H., and Lijnen P.J. Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 39 (2002) 258-263
24. Lijnen P., Petrov V., and Fagard R. Transforming growth factor-beta 1-mediated collagen gel contraction by cardiac fibroblasts. J Renin Angiotensin Aldost Syst 4 (2003) 113-118
25. Tredget E.E., Shankowsky H.A., Pannu R., et al. Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b. Plast Reconstr Surg 102 (1998) 1317-1328
26. Branton M.H., and Kopp J.B. TGF-beta and fibrosis. Microbes Infect 1 (1999) 1349-1365
27. Freedberg I.M., Tomic-Canic M., Komine M., and Blumenberg M. Keratins and the keratinocyte activation cycle. J Invest Dermatol 116 (2001) 633-640
28. Diegelmann R.F., and Evans M.C. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 9 (2004) 283-289
29. Lijnen P.J., Petrov V.V., and Fagard R.H. Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab 71 (2000) 418-435
30. Shigeyama J., Yasumura Y., Sakamoto A., et al. Increased gene expression of collagen Types I and III is inhibited by beta-receptor blockade in patients with dilated cardiomyopathy. Eur Heart J 26 (2005) 2698-2705
31. Boer R.A., Pokharel S., Flesch M., et al. Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27. J Mol Med 82 (2004) 678-687
32. Kuwahara F., Kai H., Tokuda K., et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106 (2002) 130-135
33. Ma M., Watanabe K., Wahed M.I., et al. Inhibition of progression of heart failure and expression of TGF-beta 1 mRNA in rats with heart failure by the ACE inhibitor quinapril. J Cardiovasc Pharmacol 38 suppl 1 (2001) S51-S54
34. Schonherr E., Broszat M., Brandan E., Bruckner P., and Kresse H. Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen. Arch Biochem Biophys 355 (1998) 241-248
35. Comalada M., Cardo M., Xaus J., et al. Decorin reverses the repressive effect of autocrine-produced TGF-beta on mouse macrophage activation. J Immunol 170 (2003) 4450-4456
36. Beanes S.R., Dang C., Soo C., et al. Down-regulation of decorin, a transforming growth factor-beta modulator, is associated with scarless fetal wound healing. J Pediatr Surg 36 (2001) 1666-1671
37. Giri S.N., Hyde D.M., Braun R.K., Gaarde W., Harper J.R., and Pierschbacher M.D. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol 54 (1997) 1205-1216
38. Kolb M., Margetts P.J., Sime P.J., and Gauldie J. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol 280 (2001) L1327-L1334